S100A8 and neoplasm: The S100A8 protein has been reported to promote tumor cell growth [18], to mediate endotoxin-induced cardiomyocyte dysfunction [30], to activate NK cells [31] and to aggravate post-ischemic heart failure [32] through the activation of RAGE-dependent signaling.